Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients

Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients

Terpos, E; Mougiou, A; Kouraklis, A; Chatzivassili, A; Michalis, E; Giannakoulas, N; Manioudaki, E; Lazaridou, A; Bakaloudi, V; Protopappa, M; Liapi, D; Grouzi, E; Parharidou, A; Symeonidis, A; Kokkini, G; Laoutaris, N; Vaipoulos, G; Anagnostopoulos, N; Christakis, J; Meletis, J; Bourantas, K; Zoumbos, N; Yataganas, X

URI: http://dx.doi.org/10.1046/j.1365-2141.2002.03583.x
http://62.217.125.90/xmlui/handle/123456789/2166

Ημερομηνία: 2002

Εμφάνιση πλήρους εγγραφής